Wang, Jie
Li, Chen
He, Kaijie
Kuang, Zhihui
Lu, Jia
Yao, Ying
He, Fufan
Li, Ninghuan
Li, Li
Fu, Fenggen
Wu, Zhihai
Zhou, Shuaixiang
Kang, Dian
Qiu, Xuan
Wu, Min
Liu, Yang
Cao, Xiaochao
Xu, Mengqiu
Chen, Bingliang
Wu, Weiwei
Guo, Feng
Funding for this research was provided by:
Innovent Biologics
Suzhou Municipal Science and Technology Bureau (SLJ202011, SLJ202011)
Jiangsu Commission of Health (M2020043, M2020043)
Special Technical Project of Diagnosis and Treatment of Key Clinical Diseases of Suzhou (LCZX201813, LCZX201813)
Article History
Received: 18 March 2022
Accepted: 27 July 2022
First Online: 13 August 2022
Declarations
:
: Chen Li and Feng Guo have no potential conflicts of interest to disclose. All other authors are employees of Innovent Biologics. Innovent Biologics has filed patent applications of this work.
: All authors agree to publish this article.
: All mice experiments were performed in accordance with the regulations for care and use of laboratory animals at Innovent Biologics and were approved by the Institutional Animal Care and Use Committee. All monkey experiments were approved by IACUC and performed by WestChina-Frontier PharmaTech, according to the regulations of Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC).